PSI SIG of the Year 2025, advancing modern randomization methodology in clinical trials worldwide.
Randomization Working Group
Overview
The IDSWG Randomization Working Group is a joint initiative with PSI/EFSPI and ASA-BIOP, co-chaired by Johannes Krisam, Ph.D. and Kerstine Carter (both Boehringer Ingelheim) and Alex Sverdlov, Ph.D. (Novartis).
The WG focuses on bringing awareness to modern randomization approaches that go beyond standard permuted-block methods, improving efficiency, balancing prognostic factors, and supporting the use of covariate-adaptive and response-adaptive designs.
Named PSI Special Interest Group of the Year in June 2025.
Membership
Approximately 50 active and inactive members spanning pharmaceutical industry (19), academia (24), and other organizations (7), with representation across EU/UK and the USA.
Activities
- Monthly member-only meetings
- Open learning sessions accessible to non-members
- Publications, slide sets, and educational resources
- Conference presentations at JSM, PSI annual meeting, and other venues
Resources
Visit the Randomization WG website for publications, upcoming events, and membership information.
Get Involved
To get involved, email the IDSWG at asadahshuidswg@gmail.com and your message will reach the sub-team leads.
Page last reviewed: